$1.34
-0.07-4.96%
At close: Nov 13, 4:00 PM EST
$1.33
-0.0091-0.68%
After Hours: Nov 13, 7:21 PM EST
ADC Therapeutics SA
ADCTNYSE
ADC Therapeutics fell 66.2% from $3.97 to $1.34, behind the S&P 500's +13.3%. Its worst day was Jun 4 (−57.1%), and its low came Aug 20 at $0.96.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.09 beat the $-0.29 estimate on $23.1M revenue (est. $21.0M).
+13.5% · S&P 500 −0.2%
EPS of $-0.13 beat the $-0.20 estimate on $20.9M revenue (est. $19.9M).
Story events cover the past 12 months · Times ET
−3.9% · S&P 500 −0.4%
Company to host conference call today at 4:30 p.m.
−57.1%, the year's worst day, on 13M shares, the year's heaviest volume · S&P 500 +0.4%
EPS of $-0.11 beat the $-0.21 estimate on $19.2M revenue (est. $19.1M).
−14.6% · S&P 500 +0.7%
EPS of $-0.06 beat the $-0.21 estimate on $21.7M revenue (est. $19.4M).
+5.7% · S&P 500 +2.4%
Where it ended: a close of $1.34 on Nov 13, 2026. Up next: Q4 2026 earnings on Mar 9, 2027 (EPS est. $-0.15, revenue est. $21.6M).
Nothing in the past 12 months.
All ADCT dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ADCT and SPY from Benzinga historical bars. Not investment advice.
